Selling is trivial in size and likely driven by routine portfolio diversification or tax planning. No actionable signal, monitor for any future material insider purchases or changes in selling patterns.
PCVX drugs
PCVX drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 7 $60.67entry
- T+1 · 4mo ago −3.23%α −2.92% · $58.71
- T+5 · 4mo ago −7.35%α −7.90% · $56.21
- T+20 · 4mo ago −11.77%α −13.10% · $53.53
- T+60 · 7w ago −6.21%α −8.21% · $56.90
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Insider selling cluster at Vaxcyte (PCVX): CEO Grant Pickering sold $363K and COO Jim Wassil sold $26K in open-market trades, totaling $389K over a 7-day window. The dollar amount is negligible relative to the $8.4B market cap (0.0046%), making this a routine, non-informative event.
Key Financial Metrics
Key Facts
- CEO Grant Pickering sold 6,700 shares for ~$363K at $54.27 on 2026-06-26.
- COO Jim Wassil sold 2,250 shares (including 1,788 after derivative exercise) for ~$126K at $56.03–$57.47 on 2026-07-01.
- Total cluster value of $389K is 0.0046% of PCVX's $8.4B market cap.
- No insider purchases in the cluster; all transactions are open-market sales or derivative exercises followed by sales.
Financial Impact
Insider sales of $389K, immaterial relative to market cap of $8.4B.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PCVX-1783378885585 |
Track record
29 reports on PCVX
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +10.87% at T+5 after the Oct 8, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.40 Now $61.61 −1.27% settles Dec 15
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $64.69 Now $61.61 −4.76% settles Dec 11
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $61.61 −3.57% settles Dec 7
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $61.61 −3.57% settles Dec 7
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $61.92 Now $61.61 −0.50% settles Dec 4
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $61.92 Now $61.61 −0.50% settles Dec 4
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $61.61 +1.32% settles Dec 2
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $61.61 +1.32% settles Dec 2
- Oct 9, 20265w ago 8-K Bearish 6/10 Entry $70.65 to $67.53 Now $61.61 +12.80% ▲ +4.42% +1.15% vs SPY
- Oct 8, 20265w ago 424B5 Bearish 6/10 Entry $71.38 to $63.89 Now $61.61 +13.69% ▲ +10.49% +4.93% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers